Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Nicholas A. Magnus"'
Diastereoselective Pictet-Spengler Based Synthesis of a Chiral Tetrahydroisoquinoline D1 Potentiator
Publikováno v:
The Journal of organic chemistry. 85(11)
A practical synthesis of a D1 potentiator chiral tetrahydroisoquinoline has been accomplished employing diastereoselective Pictet-Spengler methodology to access the required trans-stereochemistry. A dynamic kinetic resolution by crystallization gives
Publikováno v:
The Journal of organic chemistry. 82(12)
An efficient three-step synthesis of a series of fused bicyclic s-[1,2,4]triazolo[1,5-a]pyridines 1 was accomplished utilizing novel intermediates derived from inexpensive, commercially available hydrazides A and methyl coumalate B. A significant fea
Autor:
Prasad S. Raje, James P. Wepsiec, Nicholas A. Magnus, Chauncey D. Jones, Carlos Mateos, Amy C. DeBaillie, Alicia Torrado, Ramachandar Tokala
Publikováno v:
Organic Process Research & Development. 19:1568-1575
The development of a synthesis of an ORL-1 receptor antagonist is described. The key process improvements in the synthetic sequence include a multikilogram bromination process and the development of a convergent coupling strategy. The process improve
Autor:
Sarah O’Keeffe, Rebecca E. Deasy, Humphrey A. Moynihan, Nicholas A. Magnus, Michael E. Kopach, Denis Lynch, Douglas Patton Kjell, David Mitchell, Orla A. McNamara, Catherine N. Slattery, Anita R. Maguire, Marie Kissane, Eric D. Moher
Publikováno v:
Organic Process Research & Development. 19:344-346
There is a growing trend in Ireland toward greater collaboration between academia and the pharmaceutical industry. This is an activity encouraged at a national policy level as a means of providing researchers from academic institutions the opportunit
Autor:
Gregory A. Stephenson, Bret A. Astleford, Dana L. T. Laird, John R. Rizzo, Adam D. McFarland, Todd D. Maloney, Nicholas A. Magnus, J. Craig Ruble, James P. Wepsiec
Publikováno v:
The Journal of Organic Chemistry. 78:5768-5774
Serotonin norepinephrine reuptake inhibitor (SNRI) pyrrolidinyl ether 2 was synthesized by employing a dynamic kinetic resolution (DKR) with enantio- and diastereoselective hydogenation on β-keto-γ-lactam 8 to afford β-hydroxy-γ-lactam 9 with 96%
Autor:
Amy C. DeBaillie, Michael A. Staszak, Michael E. Laurila, Nicholas A. Magnus, Chauncey D. Jones
Publikováno v:
Organic Process Research & Development. 17:231-238
An efficient and scalable process for the preparation of a purine-based CB2 agonist was developed. The production route to the requisite purine core relies on N-acylation and sequential substitution of a 5-amino-4,6-dichloropyrimidine with two amine
Autor:
Simon E. Lawrence, Nicholas A. Magnus, Catherine N. Slattery, Rebecca E. Deasy, Denis Lynch, Anita R. Maguire, U. B. Rao Khandavilli, Leslie-Ann Clarke, Humphrey A. Moynihan
Publikováno v:
Organic letters. 18(19)
Enantio- and diastereoselective hydrogenation of β-keto-γ-lactams with a ruthenium–BINAP catalyst, involving dynamic kinetic resolution, has been employed to provide a general, asymmetric approach to β-hydroxy-γ-lactams, a structural motif comm
Autor:
Nicholas A. Magnus, Radhe K. Vaid, Jeffrey Petkus, James P. Wepsiec, Joseph F. Mick, Michael E. Laurila, Thomas Z. Gunter, J. Craig Ruble, Amy C. DeBaillie, Jeffry K. Niemeier
Publikováno v:
Organic Process Research & Development. 16:1538-1543
This contribution describes the demonstration of an asymmetric synthesis of a glucokinase activator via protonation of the enolate generated from an alkylaryl ketene and (R)-pantolactone. Additionally, a one-pot hydrolysis/oxidation protocol with lit
Autor:
Jacob R. Remacle, Amy C. DeBaillie, Christopher P. Ley, Thomas Michael Wilson, Nicholas A. Magnus, Varie David Lee, Perry Clark Heath, Timothy M. Braden, Jonas Y. Buser
Publikováno v:
Organic Process Research & Development. 16:830-835
This article describes the development and optimization of chemical reactions and subsequent multikilogram preparation of the glucokinase activator (R)-1 to fund clinical evaluation as a potential therapeutic for type II diabetes. The major process d
Autor:
James P. Wepsiec, D. Scott Coffey, Amy C. DeBaillie, Lin Wang, Iwona A. Kaluzna, Spiros Kambourakis, Nicholas A. Magnus, Chauncey D. Jones, Yangwei J. Pu
Publikováno v:
Organic Process Research & Development. 15:1377-1381
This communication describes proof of concept for an enantioselective enzyme-based synthesis of diarylmethanol (S)-1 to access mGlu2 receptor potentiators. A ketoreductase (KRED) screen was applied to benzophenone 8 to afford chiral diarylmethanol (S